Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer

Approximately 25,000 ovarian cancers are diagnosed in the U.S. annually, and 75% are in the advanced stage and largely incurable. There is critical need for early detection tools and novel treatments. Proteasomal ubiquitin receptor ADRM1 is a protein that is encoded by the ADRM1 gene. Recently, we s...

Full description

Bibliographic Details
Main Authors: Dennis J. Slamon, Richard S. Finn, Gottfried E. Konecny, Michael J. Haykinson, Nuraly K. Avliyakulov, Ondrej Kalous, Erika M. von Euw, Lee Anderson, Marlena S. Fejzo
Format: Article
Language:English
Published: MDPI AG 2013-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/14/2/3094